Tenomodulin Inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy

International Journal of Molecular Sciences

Volumn 13, Issue 11, 2012, Pages 15373-15386

  Wang, Wei ^a   Li, Zhongqiu ^a   Sato, Tatsuhiko ^b   Oshima, Yusuke ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; C57BL 6J mouse; Proliferation; Retinal neovascularization; Tenomodulin

Indexed keywords

ANGIOGENESIS INHIBITOR; CD31 ANTIGEN; TENOMODULIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; OXYGEN; TNMD PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; QUANTITATIVE ANALYSIS; RETINA BLOOD VESSEL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; RETINOPATHY; VITREOUS BODY; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PIGMENT EPITHELIUM; RETINA; RETINAL NEOVASCULARIZATION;

MUS;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD31; DISEASE MODELS, ANIMAL; MEMBRANE PROTEINS; MICE; OXYGEN; RETINA; RETINAL NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM;

EID: 84870678502     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131115373     Document Type: Article

References (39)

1. Kiyoshi, S.; Hitoshi, T.; Atsushi, O.; Hideyasu, O.; Yoshihito, H. Expression of Thrombospondin-1 in ischemia-induced retinal Neovascularization. Am. J. Pathol. 1999, 154, 343-352.
2. May, C.A.; Ohlmann, A.V.; Hammes, H.; Spandau, U.H.M. Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathy. Exp. Eye Res. 2006, 82, 341-348.
3. Josef, N.; Aqeela, A.; Hao, P.; Esteban, G.; Nan, L.; Sergio, L.C.; Sergio, C.; Polyxenie, E.S.; Lynn, C.S.; Maria, B.G. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of Oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2006, 47, 3151-3155.
4. Anat, B.; Igor, M.; Millicent, S.; Helen, G.; Golda, D.; Sabrina, G.K.; Vicktoria, V.D.; Rami, S.; Paz, E.; Alexander, F.; et al. Inhibition of oxygen-induced retinopathy in RTP801-Deficient mice. Invest. Ophthalmol. Vis. Sci. 2004, 45, 3796-3805.
5. Frank, R.N. Diabetic retinopathy. N. Engl. J. Med. 2004, 300, 48-58.
6. Zhenhua, X.; Yilin, Y.; Elia, J.D. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein Kinase C signaling. Invest. Ophthalmol. Vis. Sci. 2006, 47, 4059-4066.
7. Hanahan, D.; Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86, 353-364.
8. Elia, J.D.; Hoseong, S.Y.; Izumi, S.; Masaru, M.; Elaine, Y.; Keisuke, M.; Miyuki, K.; Lin, Y.; Kiyoshi, S.; Karen, W.; et al. Pigment Epithelium-Derived Factor Suppresses Ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 2002, 43, 821-829.
9. Smith, L.E.; Shen, W.; Perruzzi, C.; Soker, S.; Kinose, F.; Xu, X.; Robinson, G.; Driver, S.; Bischoff, J.; Zhang, B.; et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med. 1999, 5, 1390-1395.
10. Smith, L.E.; Kopchick, J.J.; Chen, W.; Knapp, J.; Kinose, F.; Daley, D.; Foley, E.; Smith, R.G.; Schaeffer, J.M. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997, 276, 1706-1709.
11. Jennifer, L.W.; Nicole, S.A.; Darren, J.K.; Richard, E. COX-2 inhibition and perinal angiogenesis in a mouse model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2003, 44, 974-979.
12. Moravski, C.J.; Kelly, D.J.; Cooper, M.E.; Gilbert, R.E.; Bertram, J.F.; Shahinfar, S.; Skinner, S.L.; Wilkinson-Berka, J.L. Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 2000, 36, 1099-1104.
13. Gibert, R.E.; Vranes, D.; Berka, J.L.; Lelly, D.J.; Cox, A.; Wu, L.L.; Stacker, S.A.; Cooper, M.E. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab. Invest. 1998, 78, 1145-1155.
14. Chabot, S.; Jabrane-Ferrat, N.; Bigot, K.; Tabiasco, J.; Provost, A.; Golzio, M.; Noman, M.Z.; Giustiniani, J.; Bellard, E.; Brayer, S.; et al. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J. Exp. Med. 2011, 208, 973-986.
15. Dawson, D.W.; Volpert, O.V.; Gillis, P.; Crawford, S.E.; Xu, H.; Benedict, W.; Bouck, N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285, 245-248.
16. Lutty, G.A.; Mello, R.J.; Chandler, C.; Fait, C.; Bennett, A.; Patz, A. Regulation of cell growth by vitreous humour. J. Cell. Sci. 1985, 76, 53-65.
17. Brem, S.; Preis, I.; Langer, R.; Brem, H.; Folkman, J. Inhibition of neo-vascularization by an extract derived from vitreous. Am. J. Ophthalmol. 1997, 84, 323-328.
18. Williams, G.A.; Eisenstein, R.; Schumacher, B.; Hsiao, K.-C. Inhibitor of vascular endothelial cell growth in the lens. Am. J. Ophthalmol. 1984, 97, 366-371.
19. Zhai, Y.; Ni, J.; Jiang, G.W.; Lu, J.; Xing, L.; Lincoln, C.; Cart, K.C.; Janat, F.; Kozak, D.; Xu, S.; et al. VEGI, a novel cytokine of the tunor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 1999, 13, 181-189.
20. Yusuke, O.; Chisa, S.; Junichi, H.; Koji, N.; Fumi, T.; Jun-ichi, M.; Yuji, H.; Yasuo, T. Expression and localization of Tenomodulin, a transmembrane type Chondromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest. Ophthalmol. Vis. Sci. 2003, 44, 1814-1822.
21. Brandau, O.; Meindl, A.; Fassler, R.; Aszodi, A. A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev. Dyn. 2001, 221, 72-80.
22. Pisani, D.F.; Pierson, P.M.; Massoudi, A.; Leclerc, L.; Chopard, A.; Marini, J.F.; Dechesne, C.A. Myodulin is a novel potential angiogenic factor in skeletal muscle. Exp. Cell. Res. 2004, 292, 40-50.
23. Shukunami, C.; Oshima, Y.; Hiraki, Y. Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem. Biophys. Res. Commun. 2001, 280, 1323-1327.
24. Yamana, K.; Wada, H.; Takahashi, Y.; Sato, H.; Kasahara, Y.; Kiyoki, M. Molecular cloning and characterization of CHM1L; a novel membrane molecule similar to chondromodulin-I. Biochem. Biophys. Res. Commun. 2001, 280, 1101-1106.
25. Docheva, D.; Hunziker, E.B.; Fassler, R.; Brandau, O. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol. Cell. Biol. 2005, 25, 699-705.
26. Oshima, Y.; Sato, K.; Tashiro, F.; Miyazaki, J.I.; Nishida, K.; Hiraki, Y.; Tano, Y.; Shukunami, C. Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. Cell. Sci. 2004, doi:10.1242/jcs.01112.
27. Shukunami, C.; Oshima, Y.; Hiraki, Y. Chondromodulin-I and tenomodulin: A new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem. Biophys. Res. Commun. 2005, 333, 299-307.
28. Haruko, F.; Shoichi, S.; Kiyoshi, Y.; Koyama, Y.; Yaoita, E.; Funaki, S.; Shirakashi, M.; Oshima, Y.; Shukunami, C.; Hiraki, Y. Haruki Abe 2 and Tadashi Yamamoto Expression and localization of angiogenic inhibitory factor, chondromodulin-I, in adult rat eye. Invest. Ophthalmol. Vis. Sci. 2001, 42, 1193-1200.
29. Smith, L.E.; Wesolowski, E.; McLellan, A.; Kostyk, S.K.; D'Amato, R.; Sullivan, R.; D'Amore, P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 1994, 35, 101-111.
30. Shibuya, M. Differential roles of vascular endothelial cell growth factor receptor-1 and Receptor-2 in Angiogenesis. Biochem. Mol. Biol. 2006, 39, 469-478.
31. 165b, an endogenous C-terminal splice variant of VEGF; inhibits retinal neovascularization in mice. Mol. Vis. 2006, 12, 626-632.
32. Lutty, G.A.; Mcleod, D.S. Retinal vascular development and oxygen-induced retinopathy: A role for adenosine. Prog. Ret. Eye Res. 2003, 22, 95-111.
33. Hidenori, I.; Masabaru, O.; Nobuyuki, K.; Takashi, K.; Onrai, M.; Yozo, M.; Takashi, M. Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy. Invest. Ophthalmol. Vis. Sci. 2001, 42, 1172-1178.
34. Irene, N.; Rosemary, D.; Lucia, Z.; Peter, S.; Stephen, P.G. C-Ab1 is required for the development of hyperoxia-induced retinopathy. J. Exp. Med. 2001, 193, 1383-1391.
35. Aiello, L.P.; Avery, R.L.; Arrigg, P.G.; Keyt, B.A.; Jampel, H.D.; Shah, S.T.; Pasquale, L.R.; Thieme, H.; Iwamoto, M.A.; Park, J.E.; et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. King N. Engl. Med.1994, 331, 1480-1487.
36. Aiello, L.P.; Pierce, E.A.; Foley, E.D.; Takaqi, H.; Chen, H.; Riddle, L.; Ferrara, N.; King, G.L.; Smith, L.E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 1995, 92, 10457-10461.
37. Adamis, A.P.; Shima, D.T.; Tolentino, M.J.; Gragoudas, E.S.; Ferrara, N.; Folkmam, J.; D'Amore, P.A.; Miller, J.W. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch. Ophthamol. 1996, 114, 66-71.
38. Miller, J.W.; Adamis, A.P.; Aiello, L.P. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab. Rev. 1997, 13, 37-50.
39. Kim, I.; Ryan, A.M.; Rohan, R.; Amano, S.; Aqular, S.; Miller, J.W.; Adamis, A.P. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest. Ophthalmol. Vis. Sci. 1999, 40, 2115-2121.